Curis (CRIS) News Today $3.70 -0.09 (-2.37%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Curis Inc (CRIS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...November 16, 2024 | uk.finance.yahoo.comCuris Inc. Receives Buy Rating: Strong Financials and Promising Clinical Trial Progress Drive Growth PotentialNovember 16, 2024 | markets.businessinsider.comCuris, Inc. (NASDAQ:CRIS) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comCuris, Inc.: Curis Provides Third Quarter 2024 Business UpdateNovember 15, 2024 | finanznachrichten.deCuris Inc. Reports Positive Q3 2024 EarningsNovember 15, 2024 | markets.businessinsider.comCuris Provides Third Quarter 2024 Business UpdateNovember 14, 2024 | prnewswire.comExamining the Future: Curis's Earnings OutlookNovember 14, 2024 | benzinga.comCuris Inc (CRIS) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 13, 2024 | gurufocus.comCuris to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024November 7, 2024 | prnewswire.comCuris price target lowered to $20 from $26 at H.C. WainwrightNovember 1, 2024 | markets.businessinsider.comCuris Inc. Gains ‘Buy’ Rating Amid Financial Stability and Promising Clinical DevelopmentsNovember 1, 2024 | markets.businessinsider.comCuris sells 2.398M shares at $4.92 in registered direct offeringOctober 29, 2024 | markets.businessinsider.comCuris Announces $12.1 Million Registered Direct and Concurrent Private PlacementOctober 29, 2024 | prnewswire.comCuris Inc (CRIS) Q2 2024 Earnings Call Highlights: Promising Clinical Progress Amid Financial ...October 9, 2024 | finance.yahoo.comBuy Rating Affirmed for Curis on Emavusertib’s Promising Clinical Data and Market PotentialSeptember 28, 2024 | markets.businessinsider.comCuris Announces the 3rd Annual Symposium on IRAK4 in CancerSeptember 23, 2024 | prnewswire.comNBC 'reaches decision on Cris Collinsworth's Sunday Night Football future'September 22, 2024 | dailymail.co.ukCuris to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare ConferenceSeptember 17, 2024 | prnewswire.comCuris to Present at Upcoming Healthcare Conferences in SeptemberSeptember 4, 2024 | prnewswire.comTruist Financial Sticks to Its Buy Rating for Curis (CRIS)August 23, 2024 | markets.businessinsider.comAnalysts' Revenue Estimates For Curis, Inc. (NASDAQ:CRIS) Are Surging HigherAugust 7, 2024 | finance.yahoo.comTruist Financial Reaffirms Their Buy Rating on Curis (CRIS)August 5, 2024 | markets.businessinsider.comCuris, Inc. (NASDAQ:CRIS) Q2 2024 Earnings Call TranscriptAugust 5, 2024 | msn.comEarnings call: Curis reports advancements in cancer treatment studiesAugust 4, 2024 | investing.comEarnings Update: Curis, Inc. (NASDAQ:CRIS) Just Reported And Analysts Are Boosting Their EstimatesAugust 4, 2024 | finance.yahoo.comBuy Rating on Curis’s Stock Amid Anticipated Data Updates and Promising Drug EfficacyAugust 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Curis on Strong Financials and Promising Emavusertib TrialsAugust 2, 2024 | markets.businessinsider.comCuris, Inc. (CRIS) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | seekingalpha.comCuris Inc Q2 Loss Decreases, But Misses EstimatesAugust 1, 2024 | markets.businessinsider.comCuris Provides Second Quarter 2024 Financial and Operating UpdateAugust 1, 2024 | prnewswire.comCuris IncJuly 25, 2024 | money.usnews.comCuris to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024July 25, 2024 | prnewswire.comCuris to Present at Upcoming Healthcare Conference in JulyJuly 10, 2024 | prnewswire.comWill Curis' TakeAim Trials Hit The Mark? July 8, 2024 | rttnews.comCuris Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)July 8, 2024 | prnewswire.comBuy Rating Affirmed for Curis’s Emavusertib Following Promising Leukemia Study ResultsMay 15, 2024 | markets.businessinsider.comCuris (NASDAQ:CRIS) Receives Buy Rating from Truist FinancialTruist Financial reaffirmed a "buy" rating and set a $26.00 target price on shares of Curis in a research note on Wednesday.May 15, 2024 | marketbeat.comCuris Announces Additional Data from TakeAim Leukemia StudyMay 14, 2024 | prnewswire.comCuris to Present Updated Data from the TakeAim Leukemia StudyMay 10, 2024 | prnewswire.comQ2 2024 Earnings Forecast for Curis, Inc. Issued By HC Wainwright (NASDAQ:CRIS)Curis, Inc. (NASDAQ:CRIS - Free Report) - Equities researchers at HC Wainwright increased their Q2 2024 earnings per share estimates for Curis in a research report issued on Wednesday, May 8th. HC Wainwright analyst E. White now anticipates that the biotechnology company will post earnings of ($2May 10, 2024 | marketbeat.comCuris Buy Rating Affirmed on Strong Earnings and Promising Emavusertib TrialsMay 8, 2024 | markets.businessinsider.comCuris, Inc. (NASDAQ:CRIS) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comCuris (NASDAQ:CRIS) Announces Quarterly Earnings Results, Misses Expectations By $0.11 EPSCuris (NASDAQ:CRIS - Get Free Report) released its earnings results on Tuesday. The biotechnology company reported ($2.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.94) by ($0.11). Curis had a negative return on equity of 169.22% and a negative net margin of 473.04%. During the same period last year, the business earned ($2.40) EPS.May 8, 2024 | marketbeat.comCRIS Stock Earnings: Curis Beats EPS, Misses Revenue for Q1 2024May 7, 2024 | investorplace.comCuris, Inc.: Curis Provides First Quarter 2024 Business UpdateMay 7, 2024 | finanznachrichten.deCuris Inc Q1 Loss beats estimatesMay 7, 2024 | markets.businessinsider.comCuris: Q1 Earnings SnapshotMay 7, 2024 | washingtonpost.comCuris Provides First Quarter 2024 Business UpdateMay 7, 2024 | prnewswire.comCuris to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024April 30, 2024 | prnewswire.comCuris, Inc. (CRIS)April 23, 2024 | finance.yahoo.com Get Curis News Delivered to You Automatically Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Watch this ASAP (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket. Click here and I’ll tell you everything you need to know. CRIS Media Mentions By Week CRIS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRIS News Sentiment▼0.200.45▲Average Medical News Sentiment CRIS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRIS Articles This Week▼81▲CRIS Articles Average Week Get Curis News Delivered to You Automatically Sign up to receive the latest news and ratings for CRIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies X4 Pharmaceuticals News Today Agenus News Today Fortress Biotech News Today SAB Biotherapeutics News Today Bolt Biotherapeutics News Today Molecular Templates News Today Cidara Therapeutics News Today Amgen News Today Vertex Pharmaceuticals News Today Gilead Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRIS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
